HS
GILD icon

HighVista Strategies’s Gilead Sciences GILD Stock Holding History

HighVista Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,900
Closed -$347K – 148
2018
Q2 		$347K Buy
4,900
+300
+7% +$21.2K 0.16% 82
2018
Q1 		$347K Sell
4,600
-400
-8% -$31.8K 0.15% 99
2017
Q4 		$358K Sell
5,000
-1,100
-18% -$83.5K 0.1% 155
2017
Q3 		$494K Buy
+6,100
New +$466K 0.11% 132
2016
Q2 		– Sell
-16,800
Closed -$1.54M – 180
2016
Q1 		$1.54M Buy
+16,800
New +$1.52M 0.29% 94
2013
Q4 		– Sell
-127,591
Closed -$8.02M – 141
2013
Q3 		$8.02M Sell
127,591
-31,936
-20% -$1.91M 1.58% 18
2013
Q2 		$8.18M Buy
+159,527
New +$8.32M 1.96% 19

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HighVista Strategies's GILD Position: Q3 2018 in Review

HighVista Strategies sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 4,900 shares — an estimated $347K sold.

HighVista Strategies first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $8.18M in Q2 2013. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • HighVista Strategies reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • HighVista Strategies sold 4,900 Gilead Sciences shares in Q3 2018, an estimated $347K.
  • HighVista Strategies first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • HighVista Strategies's Gilead Sciences position peaked at $8.18M in Q2 2013.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on HighVista Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.